Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: Results from the randomized VOYAGE 1 trial
Journal of the European Academy of Dermatology and Venereology | Mar 10, 2018
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-alpha inhibitors vs phototherapy: An observational cohort study
Journal of the American Academy of Dermatology | Mar 03, 2018
A spectrum including features of psoriasis and pityriasis rubra pilaris
Journal of the American Academy of Dermatology | Mar 01, 2018
Secukinumab demonstrates high sustained efficacy and a favorable safety profile in patients with moderate to severe psoriasis through 5 years of treatment (SCULPTURE extension study)
Journal of the European Academy of Dermatology and Venereology | Feb 20, 2018
Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis
Journal of the American Academy of Dermatology | Feb 16, 2018
A variety of information related to Medicine and Health Care. It's all here.
